Skip to content
← Full study record

NCT00687674 · MORE INFO

Limitations, agreements, and source contact

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma · Source last updated 2019-08-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
kumar.shaji@mayo.edu
organization
Mayo Clinic
title
Dr. Shaji Kumar
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
kumar.shaji@mayo.edu
organization
Mayo Clinic
title
Dr. Shaji Kumar

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice